Moberg Pharma AB (publ) (STO:MOB)

Moberg Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 6, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	512	483	475	425	228	237
Market Cap Growth	41.75%	1.65%	11.73%	86.42%	-3.61%	65.26%
Enterprise Value	284	249	170	327	87	130
Last Close Price	10.90	10.27	10.17	15.20	23.20	51.85
PE Ratio	-	-	-	-	-	31.57
Forward PE	-	69.33	69.33	69.33	69.33	69.33
PS Ratio	37.84	35.66	48.40	-	1101.38	-
PB Ratio	0.77	0.73	0.69	0.70	0.43	0.55
P/TBV Ratio	0.77	0.73	0.69	0.70	0.43	0.55
EV/Sales Ratio	20.97	18.43	17.28	-	421.77	-
Debt / Equity Ratio	0.00	0.00	0.01	0.01	0.01	0.01
Net Debt / Equity Ratio	-0.34	-0.34	-0.42	-0.09	-0.22	-0.23
Net Debt / EBITDA Ratio	8.37	8.37	0.89	2.07	6.09	5.00
Net Debt / FCF Ratio	13.06	13.06	17.56	1.68	7.09	6.45
Asset Turnover	0.02	0.02	0.02	-	0	-
Inventory Turnover	1.49	1.49	0.61	-	-	-
Quick Ratio	14.45	14.45	17.59	2.99	4.74	6.68
Current Ratio	14.71	14.71	17.95	3.38	4.77	6.74
Return on Equity (ROE)	-4.03%	-4.03%	-39.32%	-3.69%	-3.25%	-3.91%
Return on Assets (ROA)	-2.52%	-2.52%	-30.29%	-2.91%	-2.53%	-2.65%
Return on Invested Capital (ROIC)	-6.36%	-6.71%	-68.21%	-5.76%	-5.47%	-5.49%
Return on Capital Employed (ROCE)	-4.20%	-4.20%	-47.10%	-4.50%	-3.80%	-4.50%
Earnings Yield	-5.32%	-5.64%	-53.72%	-4.96%	-6.89%	3.17%
FCF Yield	-	-3.62%	-3.47%	-7.81%	-7.39%	-6.47%
Buyback Yield / Dilution	-23.78%	-23.78%	-138.46%	-109.19%	-76.28%	-127.45%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.